Avantax Planning Partners, Inc. T2 Biosystems, Inc. Transaction History

Avantax Planning Partners, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Jan 28, 2022	BUY	$0.46 - $0.94 $32,200 - $65,800	70,000 Added 173.81%	110,273 $57,000
Q1 2021 May 06, 2021	BUY	$1.32 - $3.79 $53,160 - $152,634	40,273 New	40,273 $65,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $3.74M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Avantax Planning Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Avantax Planning Partners, Inc. with notifications on news.